These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 29534334)
1. Synthesis, Biological Evaluation and Molecular Modeling Studies of Propargyl-Containing 2,4,6-Trisubstituted Pyrimidine Derivatives as Potential Anti-Parkinson Agents. Kumar B; Kumar M; Dwivedi AR; Kumar V ChemMedChem; 2018 Apr; 13(7):705-712. PubMed ID: 29534334 [TBL] [Abstract][Full Text] [Related]
2. Dipropargyl substituted diphenylpyrimidines as dual inhibitors of monoamine oxidase and acetylcholinesterase. Kumar B; Kumar V; Prashar V; Saini S; Dwivedi AR; Bajaj B; Mehta D; Parkash J; Kumar V Eur J Med Chem; 2019 Sep; 177():221-234. PubMed ID: 31151057 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, monoamine oxidase inhibitory activity and computational study of novel isoxazole derivatives as potential antiparkinson agents. Agrawal N; Mishra P Comput Biol Chem; 2019 Apr; 79():63-72. PubMed ID: 30731360 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling studies of phenyl-/benzhydrylpiperazine derivatives as potential MAO inhibitors. Kumar B; Sheetal ; Mantha AK; Kumar V Bioorg Chem; 2018 Apr; 77():252-262. PubMed ID: 29421700 [TBL] [Abstract][Full Text] [Related]
5. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051 [TBL] [Abstract][Full Text] [Related]
6. Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors. Li S; Lv X; Cheng K; Tian Y; Huang X; Kong H; Duan Y; Han J; Liao C; Xie Z Bioorg Med Chem Lett; 2019 May; 29(9):1090-1093. PubMed ID: 30833108 [TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase inhibitory activities of heterocyclic chalcones. Minders C; Petzer JP; Petzer A; Lourens AC Bioorg Med Chem Lett; 2015 Nov; 25(22):5270-6. PubMed ID: 26432037 [TBL] [Abstract][Full Text] [Related]
8. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease. Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824 [TBL] [Abstract][Full Text] [Related]
9. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Engelbrecht I; Petzer JP; Petzer A Bioorg Med Chem Lett; 2015 May; 25(9):1896-900. PubMed ID: 25857942 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by indole and benzofuran derivatives. Prins LH; Petzer JP; Malan SF Eur J Med Chem; 2010 Oct; 45(10):4458-66. PubMed ID: 20674099 [TBL] [Abstract][Full Text] [Related]
12. MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains. Can ÖD; Osmaniye D; Demir Özkay Ü; Sağlık BN; Levent S; Ilgın S; Baysal M; Özkay Y; Kaplancıklı ZA Eur J Med Chem; 2017 May; 131():92-106. PubMed ID: 28301816 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors. Qhobosheane MA; Petzer A; Petzer JP; Legoabe LJ Bioorg Med Chem; 2018 Nov; 26(20):5531-5537. PubMed ID: 30279044 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of biaryl derivatives for structural characterization of selective monoamine oxidase B inhibitors toward Parkinson's disease therapy. Yeon SK; Choi JW; Park JH; Lee YR; Kim HJ; Shin SJ; Jang BK; Kim S; Bahn YS; Han G; Lee YS; Pae AN; Park KD Bioorg Med Chem; 2018 Jan; 26(1):232-244. PubMed ID: 29198609 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and monoamine oxidase inhibitory activity of new pyridazine-, pyrimidine- and 1,2,4-triazine-containing tricyclic derivatives. Carotti A; Catto M; Leonetti F; Campagna F; Soto-Otero R; Méndez-Alvarez E; Thull U; Testa B; Altomare C J Med Chem; 2007 Nov; 50(22):5364-71. PubMed ID: 17910428 [TBL] [Abstract][Full Text] [Related]
16. 2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors. Legoabe LJ; Petzer A; Petzer JP Drug Des Devel Ther; 2015; 9():3635-44. PubMed ID: 26203229 [TBL] [Abstract][Full Text] [Related]
17. Pyrimido[1,2-b]indazole derivatives: Selective inhibitors of human monoamine oxidase B with neuroprotective activity. Jismy B; El Qami A; Pišlar A; Frlan R; Kos J; Gobec S; Knez D; Abarbri M Eur J Med Chem; 2021 Jan; 209():112911. PubMed ID: 33071056 [TBL] [Abstract][Full Text] [Related]
18. 3-Coumaranone derivatives as inhibitors of monoamine oxidase. Van Dyk AS; Petzer JP; Petzer A; Legoabe LJ Drug Des Devel Ther; 2015; 9():5479-89. PubMed ID: 26491258 [TBL] [Abstract][Full Text] [Related]
19. Indoles and 1-(3-(benzyloxy)benzyl)piperazines: Reversible and selective monoamine oxidase B inhibitors identified by screening an in-house compound library. Knez D; Hrast M; Frlan R; Pišlar A; Žakelj S; Kos J; Gobec S Bioorg Chem; 2022 Feb; 119():105581. PubMed ID: 34990933 [TBL] [Abstract][Full Text] [Related]
20. Benzyloxynitrostyrene analogues - A novel class of selective and highly potent inhibitors of monoamine oxidase B. Van der Walt MM; Terre'Blanche G; Petzer JP; Petzer A Eur J Med Chem; 2017 Jan; 125():1193-1199. PubMed ID: 27855360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]